Invex Therapeutics Statistics
Total Valuation
ASX:IXC has a market cap or net worth of AUD 5.64 million. The enterprise value is -169,922.
Market Cap | 5.64M |
Enterprise Value | -169,922 |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASX:IXC has 75.15 million shares outstanding. The number of shares has increased by 0.62% in one year.
Current Share Class | n/a |
Shares Outstanding | 75.15M |
Shares Change (YoY) | +0.62% |
Shares Change (QoQ) | +0.56% |
Owned by Insiders (%) | 26.31% |
Owned by Institutions (%) | 26.51% |
Float | 48.16M |
Valuation Ratios
The trailing PE ratio is 49.64.
PE Ratio | 49.64 |
Forward PE | n/a |
PS Ratio | 4.65 |
PB Ratio | 1.05 |
P/TBV Ratio | 1.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.49 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22
Current Ratio | 12.22 |
Quick Ratio | 12.22 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.14% and return on invested capital (ROIC) is -1.36%.
Return on Equity (ROE) | 2.14% |
Return on Assets (ROA) | -1.20% |
Return on Invested Capital (ROIC) | -1.36% |
Return on Capital Employed (ROCE) | -2.16% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.20 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.22 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.07 |
200-Day Moving Average | 0.07 |
Relative Strength Index (RSI) | 86.24 |
Average Volume (20 Days) | 7,202 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:IXC had revenue of AUD 1.21 million and earned 114,355 in profits. Earnings per share was 0.00.
Revenue | 1.21M |
Gross Profit | 1.21M |
Operating Income | -116,470 |
Pretax Income | 114,355 |
Net Income | 114,355 |
EBITDA | n/a |
EBIT | -116,470 |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 5.81 million in cash and n/a in debt, giving a net cash position of 5.81 million or 0.08 per share.
Cash & Cash Equivalents | 5.81M |
Total Debt | n/a |
Net Cash | 5.81M |
Net Cash Per Share | 0.08 |
Equity (Book Value) | 5.38M |
Book Value Per Share | 0.07 |
Working Capital | 5.38M |
Cash Flow
Operating Cash Flow | -368,362 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -9.61% and 9.43%.
Gross Margin | 100.00% |
Operating Margin | -9.61% |
Pretax Margin | 9.43% |
Profit Margin | 9.43% |
EBITDA Margin | n/a |
EBIT Margin | -9.61% |
FCF Margin | n/a |
Dividends & Yields
ASX:IXC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.62% |
Shareholder Yield | -0.62% |
Earnings Yield | 2.03% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ASX:IXC has an Altman Z-Score of 3.88.
Altman Z-Score | 3.88 |
Piotroski F-Score | n/a |